PhytoSwiss Pharma: AI-driven synergies for patentable products promoting healthy life Company purpose: unlocking best attainable synergies of clinically-validated ingredients for tackling various diseases and indications, and promoting healthy life. A new paradigm in product development for faster R&D and market approval. Follow us on: www.linkedin/in/bassand twitter.com/PhytoSwissPharm www.phytoswisspharma.ch Platform: • Using a unique proprietary AI-driven versatile platform for fast selection of best synergistic patentable combos. • May be used for any type of combos (drugs, supplements, food, feed, cosmetics…). • May be used for any kind of turnkey or bespoke products. • Uses convergence of state-of-the-art processes & technologies (AI, deep mining, preclinical optimization, Evidence-Based Medicine, reverse pharmacology, GMP, ICH IVb...). • Artificial Intelligence (AI) versatile platform for uncovering best attainable synergies in combination drugs and supplements (combos). PhytoSwiss Pharma, a Swiss company anticipating new R&D and market trends: • Company focus: Unlock best attainable synergies of botanicals & other ingredients (vitamins, minerals, fatty acids...) for improving health and beauty of billions of people worldwide. • Dietary supplement focus: Best synergistic supplements targeted at various indications. Turnkey or bespoke supplements upon demand. • Cosmetics focus: New programs using PhytoSwiss Pharma platform for developing really potent synergistic combos for tackling high unmet needs in the cosmetics arena (nutricosmetics "beauty from within", cosmetic products). • Disease prevention focus: In-house developed PhytoSwiss Pharma products target prevention of cardio-metabolic diseases (diabetes, obesity, NAFLD/NASH, hypertension, dyslipidemia...) and their complications, a major health problem and spreading pandemics.